Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDELVION extension study in hemophilia B
2012-005489-37Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Aug 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of albutrepenonacog alfa in hemophilia B (HB), sponsored by CSL Limited. Started Aug 2013; status: completed.
02
Drugs
albutrepenonacog alfa
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on 2012-005489-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005489-37.